Synonyms: ONO 5334 | ONO5334
Compound class:
Synthetic organic
Comment: ONO-5334 is a cysteine protease inhibitor with activity against cathepsin K. It was an oral drug lead that was considered as a bone resorption inhibitor for the treatment of postmenopausal osteoporosis. ONO-5334 has some antiviral activity against SARS-CoV-2, and antagonises viral replication in human iPSC-derived pneumocyte-like cells [2].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N-[(1S)-3-[(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazinyl]-1-(oxan-4-yl)-2,3-dioxopropyl]cycloheptanecarboxamide |
Synonyms ![]() |
ONO 5334 | ONO5334 |
Database Links ![]() |
|
CAS Registry No. | 868273-90-9 (source: PubChem) |
GtoPdb PubChem SID | 405067338 |
PubChem CID | 11582982 |
Search Google for chemical match using the InChIKey | BTZCSXIUAFVRTE-CHGLIHOBSA-N |
Search Google for chemicals with the same backbone | BTZCSXIUAFVRTE |
UniChem Compound Search for chemical match using the InChIKey | BTZCSXIUAFVRTE-CHGLIHOBSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | BTZCSXIUAFVRTE-CHGLIHOBSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
ONO-5334 (links to external site)
Cat. No. HY-108044 |